Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
109.20
+4.15 (3.95%)
At close: May 19, 2026, 4:00 PM EDT
109.20
0.00 (0.00%)
After-hours: May 19, 2026, 4:10 PM EDT
Palvella Therapeutics Employees
Palvella Therapeutics had 29 employees as of December 31, 2025. The number of employees increased by 15 or 107.14% compared to the previous year.
Employees
29
Change (1Y)
15
Growth (1Y)
107.14%
Revenue / Employee
n/a
Profits / Employee
-$1,699,897
Market Cap
1.57B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 29 | 15 | 107.14% |
| Dec 31, 2024 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Novavax | 749 |
| Recursion Pharmaceuticals | 600 |
| Ardelyx | 489 |
| Nuvation Bio | 307 |
| Monte Rosa Therapeutics | 187 |
| Precigen | 160 |
| Inhibrx Biosciences | 110 |
PVLA News
- 4 days ago - Palvella Therapeutics announces new data from TOIVA trial of Qtorin - TheFly
- 4 days ago - Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology - GlobeNewsWire
- 6 days ago - Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market - GlobeNewsWire
- 7 days ago - Palvella Therapeutics initiated with an Overweight at Stephens - TheFly
- 12 days ago - Palvella Therapeutics reports Q1 EPS ($1.20) vs. (74c) last year - TheFly
- 12 days ago - Palvella Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - Palvella Therapeutics Earnings release: Q1 2026 - Filings
- 12 days ago - Palvella Therapeutics Quarterly report: Q1 2026 - Filings